Psychiatry · Aica, HI
NPI
1982780128
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
98 1247 Kaahumanu Street, Suite 312a
Aica, HI, 96701
Phone (808) 488-7888
Medicare paid, 2024
$37K
651 services
Medicare patients, 2024
50
Average age 74
Drug cost, 2024
$1.7M
2,487 prescriptions
Company payments, 2025
$5,485
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Zafrani was code 90836 (psychotherapy - nongroup), 323 times for 49 patients. In total Michael B Zafrani billed 651 services in 4 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90836 Psychotherapy - Nongroup | Office | 323 | 49 | $59.40 | $19K |
| 99213 Office E&M - Established | Office | 323 | 49 | $53.01 | $17K |
By year: 2022 $37K for 693 services; 2023 $35K for 679 services; 2024 $37K for 651 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Zafrani prescribed most often to Medicare patients was Alprazolam, with 144 prescriptions and refills. In total Michael B Zafrani wrote 2,487 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 144 | 184 | 21 | $2,436 |
| Quetiapine Fumarate Generic | 144 | 221 | 21 | $6,058 |
| Aripiprazole Generic | 128 | 184 | 22 | $14K |
| Vraylar Cariprazine Hcl | 94 | 94 | Under 11 | $147K |
| Clonazepam Generic | 85 | 89 | 13 | $1,551 |
| Perseris Risperidone | 79 | 79 | Under 11 | $230K |
| Fluoxetine Hcl Generic | 78 | 131 | 14 | $1,717 |
| Ziprasidone Hcl Generic | 75 | 83 | Under 11 | $7,148 |
| Divalproex Sodium Er Divalproex Sodium | 69 | 107 | 13 | $11K |
| Risperidone Generic | 69 | 81 | 12 | $2,907 |
| Haloperidol Generic | 64 | 71 | Under 11 | $3,732 |
| Bupropion Xl Bupropion Hcl | 63 | 101 | Under 11 | $1,774 |
| Clozapine Generic | 63 | 63 | Under 11 | $6,780 |
| Benztropine Mesylate Generic | 60 | 104 | Under 11 | $1,637 |
| Gabapentin Generic | 53 | 67 | Under 11 | $773 |
Brand drugs: 531 claims; generic drugs: 1,956 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Zafrani $5,485 ($5,485 in general payments such as food, travel and fees) from 11 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $1,510.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 32 | $1,510 |
| Neurocrine BioSciences, Inc. NBIX | 34 | $858 |
| Abbvie Inc. ABBV | 31 | $816 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 21 | $583 |
| Lundbeck LLC | 17 | $473 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $424 |
| Vanda Pharmaceuticals Inc. VNDA | 14 | $262 |
| Janssen Pharmaceuticals, Inc JNJ | 9 | $224 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 9 | $182 |
| Axsome Therapeutics, Inc. AXSM | 5 | $126 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.